The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Bertrand William C Jr since 2015.
This trader's CIK number is 1291937.
At the time of last reporting, Bertrand William C Jr was the Chief Operating Officer of Adaptimmune Therapeutics Plc. (stock ticker symbol ADAP).
Also see all insider trading activities at Adaptimmune Therapeutics Plc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ADAP | 0 | $0 | 212,584 | $5,314 | 0 | $0 |
| 2024 | ADAP | 0 | $0 | 32,818 | $24,234 | 0 | $0 |
| 2023 | ADAP | 0 | $0 | 16,840 | $29,516 | 0 | $0 |
| 2022 | ADAP | 0 | $0 | 13,876 | $49,500 | 0 | $0 |
| 2021 | ADAP | 0 | $0 | 10,108 | $51,044 | 0 | $0 |
| 2020 | ADAP | 207,000 | $143,865 | 6,128 | $16,785 | 0 | $0 |
| 2019 | ADAP | 0 | $0 | 2,271 | $12,192 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | ARDX | 5,000 | $100,000 | 0 | $0 | 0 | $0 |
1. Adaptimmune Therapeutics Plc (ADAP)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-28 | ADAP | Sale | 207,000 | .01 | 2,070 |
| 2025-01-17 | ADAP | Sale | 5,584 | .58 | 3,244 |
| 2024-01-16 | ADAP | Sale | 4,681 | .79 | 3,697 |
| 2024-01-17 | ADAP | Sale | 18,908 | .67 | 12,725 |
| 2024-01-12 | ADAP | Sale | 5,220 | .85 | 4,457 |
| 2024-01-11 | ADAP | Sale | 4,009 | .84 | 3,355 |
| 2023-01-17 | ADAP | Sale | 4,440 | 1.86 | 8,249 |
| 2023-01-11 | ADAP | Sale | 3,843 | 1.75 | 6,713 |
| 2023-01-12 | ADAP | Sale | 4,973 | 1.71 | 8,483 |
| 2023-01-04 | ADAP | Sale | 3,584 | 1.69 | 6,071 |
| 2022-01-18 | ADAP | Sale | 4,368 | 3.19 | 13,942 |
| 2022-01-11 | ADAP | Sale | 3,770 | 3.56 | 13,409 |
| 2022-01-12 | ADAP | Sale | 2,248 | 3.54 | 7,966 |
| 2022-01-04 | ADAP | Sale | 3,490 | 4.06 | 14,183 |
| 2021-07-02 | ADAP | Sale | 4,375 | 4.26 | 18,659 |
| 2021-01-12 | ADAP | Sale | 2,234 | 6.15 | 13,743 |
| 2021-01-04 | ADAP | Sale | 3,499 | 5.33 | 18,642 |
| 2020-12-14 | ADAP | Buy | 207,000 | .69 | 143,865 |
| 2020-01-14 | ADAP | Sale | 2,397 | 5.13 | 12,308 |
| 2020-01-06 | ADAP | Sale | 3,731 | 1.20 | 4,477 |
| 2019-01-14 | ADAP | Sale | 2,271 | 5.37 | 12,192 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-12-17 | ARDX | Buy | 5,000 | 20.00 | 100,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bertrand William C Jr (Chief Operating Officer of Adaptimmune Therapeutics Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.